Press Release September 19, 2023 DelveInsight Highlights Major Advances, Transformative Therapies, and 5+ Leading Players Wheeling the Pre-Eclampsia Clinical Trial Pipeline Landscape
Press Release September 19, 2023 Seizing Opportunities in the Crypto Market – Gambit enters the DEX field
Press Release September 19, 2023 Constipation Pipeline Insights, Clinical Trials Assessment, and NDA Approvals 2023 (Updated)
Press Release September 19, 2023 Alpha-1 Antitrypsin Deficiency Pipeline, Clinical Trials Assessment, and NDA Approvals 2023 (Updated)
Press Release September 19, 2023 Cirrhosis Pipeline, Clinical Trials Assessment, and NDA Approvals 2023 (Updated)
Press Release September 19, 2023 Ulcerative Colitis Pipeline, Clinical Trials Assessment, and NDA Approvals 2023 (Updated)
Press Release September 19, 2023 Optic Nerve Diseases Market to Witness Growth by 2032, Estimates DelveInsight | Allergan, Mallinckrodt Pharmaceuticals, Novartis, Santen Pharmaceutical, Bausch Health, Pfizer, Teva Pharmaceutical
Press Release September 19, 2023 Ischemic Stroke Market to Witness Growth by 2032, Estimates DelveInsight | Roche, Boehringer Ingelheim, Bayer, Pfizer, Biogen, Daiichi Sankyo, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca
Press Release September 19, 2023 Neurostimulation Devices Market Analysis, Devices, Applications, Demand Growth, Companies and Competitive Landscape by DelveInsight
Press Release September 19, 2023 Acral Lentiginous Melanoma Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies by DelveInsight | Atreca, AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Lilly, Johnson & Johnson